[1]
Usha Adiga et al. 2021. Determination of Cost of Illness of Type 2 Diabetes Mellitus in Tertiary Care Setting. Technological Innovation in Pharmaceutical Research Vol. 11. (Aug. 2021), 78–97. DOI:https://doi.org/10.9734/bpi/tipr/v11/9858D.